Previously submitted to: JMIR Dermatology (no longer under consideration since Mar 16, 2023)
Date Submitted: Jul 19, 2022
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Patient’s perceptions of synchronous teledermatology: narrative review
ABSTRACT
Background:
Despite global synchronous teledermatology (SynTD) use during the pandemic, existing studies have not reviewed patient perceptions of SynTD or compared these to face-to-face consultation (FTFC) perceptions.
Objective:
We aim to evaluate and compare the forenamed perceptions alongside assessing patients preferred consultation modality.
Methods:
We searched four public databases for studies on SynTD patient perceptions.
Results:
Twelve studies were eligible, all demonstrating SynTD satisfaction. Those comparing TC (n=3) and VC (n=4) to FTFC revealed lower and similar satisfaction, respectively, however, overall, there was no preferred modality. Patients favoured SynTD's convenience but valued FTFC's in-person examinations and privacy. Most (80.0%, n=4) of the five studies querying future preferences demonstrated patient interest in prospective SynTD.
Conclusions:
Despite patient interest in general SynTD, FTFC results in higher satisfaction than TC and similar satisfaction to VC. Future research areas include, comparing TC and VC perceptions and developing a TD satisfaction measure.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.